Sun Pharma Parent Taro Pharmaceutical Industries Updates On Ransomware Incident

Author: Benzinga Newsdesk | March 27, 2023 08:57am

 As previously disclosed, on March 1, 2023, Sun Pharmaceutical Industries Ltd. (“Sun”), the parent company of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro”), disclosed that it is experiencing an information technology (“IT”) security incident. Upon learning that the incident had impacted Taro on March 3, 2023, Taro, in conjunction with Sun, promptly took steps to contain and remediate the impact on Taro, including employing containment protocols to mitigate the threat and additional measures to ensure the integrity of its IT systems infrastructure and data. These measures are underway as Taro works in conjunction with Sun to utilize global cyber security experts and enhanced security measures to address and mitigate the impact of the incident. A ransomware group has claimed responsibility for this incident.

Posted In: TARO